DNA vaccines: A simple DNA sensing matter?

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 10, 2013, Pages 2216-2221

  Coban, Cevayir ^a   Kobiyama, Kouji ^a,b   Jounai, Nao ^b   Tozuka, Miyuki ^b   Ishii, Ken J ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Adjuvant; DNA vaccine; STING; TBK1; Type I interferon

Indexed keywords

ABSENCE IN MELANOMA 2; CELL DNA; CHEMOKINE; CYCLIC GMP; DEAD BOX PROTEIN; DNA BINDING PROTEIN; DNA DIRECTED RNA POLYMERASE III; DNA VACCINE; DOUBLE STRANDED DNA; GAMMA INTERFERON INDUCIBLE PROTEIN 16; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE H2B; INFLAMMASOME; PLASMID DNA; PLASMID VECTOR; PROTEIN DDX41; PROTEIN STING; PROTEIN TRIM56; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VADIMEZAN; Z DNA BINDING PROTEIN;

ADAPTIVE IMMUNITY; AIM2 GENE; CELLULAR IMMUNITY; CGAS GENE; DDX41 GENE; DNA DETERMINATION; DNA IMMUNIZATION; DNA METABOLISM; DNA PROTEIN COMPLEX; DNA TRANSFECTION; DRUG SAFETY; GENE; H2B GENE; HEPATITIS B; HMGB GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IFI16 GENE; IMMUNOGENICITY; INFECTIOUS HEMATOPOIETIC NECROSIS; INFLUENZA; INNATE IMMUNITY; MALARIA; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; MELANOMA; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; RECOMBINANT PLASMID; REVIEW; STING GENE; TRIM56 GENE; VETERINARY MEDICINE; WEST NILE FEVER; ZBP1 GENE;

ADJUVANT; DNA VACCINE; STING; TBK1; TYPE I INTERFERON;

ADAPTIVE IMMUNITY; ADJUVANTS, IMMUNOLOGIC; ANIMALS; DNA; HUMANS; IMMUNITY, INNATE; RECOMBINANT PROTEINS; VACCINES, DNA;

EID: 84885142956     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.25893     Document Type: Review

References (55)

1. Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011;239:62-84; PMID:21198665; http://dx.doi. Org/10.1111/j.1600- 065X.2010.00980.x
2. Ferraro B, Morrow MP, Hutnick NA, Shin TH, Lucke CE, Weiner DB. Clin Infect Dis 2011;53:296-302; http://dx.doi.org/10.1093/cid/cir334.
3. Li L, Saade F, Petrovsky N. The future of human DNA vaccines. J Biotechnol 2012;162:171-82; PMID:22981627; http://dx.doi.org/10.10l6/j.jbiotec. 2012.08.012
4. Davis BS, Chang GJ, Cropp B, Roehrig JT, Martin DA, Mitchell CJ, et al. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzymelinked immunosorbent assays. J Virol 2001;75:4040-7; PMID:11287553; http://dx.doi.org/10.1128/JVI.75.9.4040-4047.2001
5. Bergman PJ, McKnight J, Novosad A, Charney S, Farrelly J, Craft D, et al. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin Cancer Res 2003;9:1284-90; PMID:12684396
6. Corbeil S, Lapatra SE, Anderson ED, Jones J, Vincent B, Hsu YL, et al. Evaluation of the protective immunogenicity of the N, P, M, NV and G proteins of infectious hematopoietic necrosis virus in rainbow trout oncorhynchus my kiss using DNA vaccines. Dis Aquat Organ 1999;39:29-36; PMID:11407402; http://dx.doi.org/10.3 35 4/dao03 9 02 9
7. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 2006;7:40-8; PMID: 16286919; http://dx.doi.org/10.1038/ nil282
8. Desmet CJ, Ishii KJ. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 2012;12:479-91; PMID=22728526; http://dx.doi.org/10.1038/nri3247
9. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 2008;451:725-9; PMID: 18256672; http://dx. doi.org/10.10 38/nature065 37
10. Sardesai NY, Weiner DB. Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 2011;23:421-9; PMID:21530212; http://dx.doi.org/10.1016/j.coi.2011.03.008
11. Gothelf A, Gehl J. What you always needed to know about electroporation based DNA vaccines. Hum Vaccin Immunother 2012;8:1694-702; PMID:23111168; http://dx.doi.org/10.4l61/hv. 22062
12. Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferondependent innate immunity. Nature 2009;461:788-92; PMID: 19776740; http://dx.doi.org/10.1038/nature08476
13. Ishii KJ, Akira S. Potential link between the immune system and metabolism of nucleic acids. Curr Opin Immunol 2008;20:524-9; PMID: 18662775; http://dx.doi.org/10.1016/j.coi.2008.07.002
14. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007;448:501-5; PMID: 17618271; http://dx.doi.org/10.1038/ nature06013
15. Lippmann J, Rothenburg S, Deigendesch N, Eitel J, Meixenberger K, Van Laak V, et al. IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI). Cell Microbiol 2008;10:2579-88; PMID: 18771559; http://dx.doi.org/l 0.1111/j. 1462-5822.2008.01232.x
16. Burckstummer T, Baumann C, Bliiml S, Dixit E, Diirnberger G, Jahn H, et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009;10:266-72; PMID:19158679; http://dx.doi.org/10.1038/ni. 1702
17. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM 2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009;458:509-13; PMID: 19158676; http://dx.doi.org/10.1038/nature07710
18. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009;458:514-8; PMID:19158675; http://dx.doi.org/10.103 8/nature07725
19. Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009;323:1057-60; PMID:19131592; http://dx. doi.org/10.1126/ science. 1169841
20. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010;11:997-1004; PMID:20890285; http://dx.doi.org/10.1038/ni. 1932
21. Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009;138:576-91; PMID: 19631370; http://dx.doi.org/10.1016/j.cell.2009.06.015
22. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-5; PMID:12110890; http://dx.doi.org/10.1038/nature00858
23. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 2009;462:99-103; PMID: 19890330; http://dx.doi.org/10.1038/ natureO 8512
24. Kobiyama K, Takeshita F, Jounai N, Sakaue-Sawano A, Miyawaki A, Ishii KJ, et al. Extrachromosomal histone H2B mediates innate antiviral immune responses induced by intracellular double-stranded DNA. J Virol 2010;84:822-32; PMID:19906922; http://dx.doi.org/10.1128/JVI.01339-09
25. Barber GN. Cytoplasmic DNA innate immune pathways. Immunol Rev 2011;243:99-108; PMID:21884170; http://dx.doi.org/10.1 111/j. 1600-065X.2011.01051.x
26. Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011;478:515-8; PMID:21947006; http://dx.doi.org/10.103 8/nature10429
27. Tsuchida T, Zou J, Saitoh T, Kumar H, Abe T, Matsuura Y, et al. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010;33:765-76; PMID:21074459; http://dx.doi. Org/10.1016/j.immuni.2010.10.013
28. Parvatiyar K, Zhang Z, Teles RM, Ouyang S, Jiang Y, Iyer SS, et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol 2012;13:1155-61; PMID:23142775; http://dx.doi.org/10.1038/ni.2460
29. Ouyang S, Song X, Wang Y, Ru H, Shaw N, Jiang Y, et al. Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity 2012;36:1073-86; PMID:22579474; http://dx.doi.org/10.1016/j.immuni.2012.03.019
30. Bowie AG. Innate sensing of bacterial cyclic dinucleotides: more than just STING. Nat Immunol 2012;13:1137-9; PMID:23160208; http://dx.doi.org/10. 1038/ni.2469
31. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013;339:786-91; PMID:23258413; http://dx.doi.org/10.1126/science. 1232458
32. Babiuk S, Mookherjee N, Pontarollo R, Griebel P, Van DrunenLittel-Van Den Hurk S, Hecker R, et al. TLR9-/-and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 2004;113:114-20; PMID: 15312142; http://dx.doi.org/10.1111/j.1365-2567.2004.01938.x
33. Rottembourg D, Filippi CM, Bresson D, Ehrhardt K, Estes EA, Oldham JE, et al. Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection. J Immunol 2010;184:7100-7; PMID:20483769; http://dx.doi.org/l 0.4049/jimmunol.0803935
34. Coban C, Kobiyama K, Aoshi T, Takeshita F, Horii T, Akira S, et al. Novel strategies to improve DNA vaccine immunogenicity. Curr Gene Ther 2011;11:479-84; PMID:22023477; http://dx.doi.org/10.2174/156652311798192815
35. Okuda K, Kawamoto S, Fukushima J. Cytokine and costimulatory factor-encoding plasmids as adjuvants for DNA vaccination. Methods Mol Med 2000;29:197-204; PMID:21374321
36. Sasaki S, Amara RR, Oran AE, Smith JM, Robinson HL. Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nat Biotechnol 2001;19:543-7; PMID:11385458; http://dx.doi.org/10.1038/89289
37. Shirota H, Petrenko L, Hattori T, Klinman DM. Contribution of IRF-3 mediated IFNbeta production to DNA vaccine dependent cellular immune responses. Vaccine 2009;27:2144-9; PMID: 19356618; http://dx.doi.org/10.1016/j.vaccine. 2009.01.134
38. Takeshita F, Tanaka T, Matsuda T, Tozuka M, Kobiyama K, Saha S, et al. Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity. J Virol 2006;80:6218-24; PMID:16775309; http://dx.doi.org/10.1128/JVI.00121-06
39. Luke JM, Simon GG, Soderholm J, Errett JS, August JT, Gale M Jr., et al. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. J Virol 2011;85:1370-83; PMID:21106745; http://dx.doi.org/10.1128/ JVI.01250-10
40. Liniger M, Summerfield A, Ruggli N. MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens. PLoS One 2012;7:e49952; PMID:23227156; http://dx.doi.org/10.1371/journal. pone.0049952
41. Muthumani G, Laddy DJ, Sundaram SG, Fagone P, Shedlock DJ, Kannan S, et al. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells. Immunology 2009;128(Suppl):e612-20; PMID: 19740322; http://dx.doi.org/10.1111/j.1365-2567. 2009.03044. X
42. Fagone P, Shedlock DJ, Bao H, Kawalekar OU, Yan J, Gupta D, et al. Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination. Gene Ther 2011;18:1070-7; PMID:21544096; http://dx. doi.org/10.103 8/gt.2 011.59
43. Lladser A, Mougiakakos D, Tufvesson H, Ligtenberg MA, Quest AF, Kiessling R, et al. DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity. Mol Ther 2011;19:594-601; PMID:21157438; http://dx.doi.org/10.1038/mt.2010.268
44. Castaldello A, Sgarbanti M, Marsili G, Brocca-Cofano E, Remoli AL, Caputo A, et al. Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination. J Cell Physiol 2010;224:702-9; PMID:20432465; http://dx.doi.org/10.1002/jcp. 22169
45. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, et al. Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 2001;167:2602-7; PMID:11509601
46. Marichal T, Ohata K, Bedoret D, Mesnil C, Sabatel C, Kobiyama K, et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med 2011;17:996-1002; PMID:21765404; http://dx.doi.org/10.103 8/nm.2403
47. McWhirter SM, Barbalat R, Monroe KM, Fontana MF, Hyodo M, Joncker NT, et al. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J Exp Med 2009;206:1899-911; PMID: 19652017; http://dx.doi.org/10.1084/jem.20082874
48. Smith HA, Klinman DM. The regulation of DNA vaccines. Curr Opin Biotechnol 2001;12:299-303; PMID: 11404109; http://dx.doi.org/10.1016/S0958-1669 (00) 00215-9
49. Chen W, Kuolee R, Yan H. The potential of 3', 5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant. Vaccine 2010;28:3080-5; PMID:20197136; http://dx.doi. Org/10.1016/j.vaccine.2010.02.081
50. Pedersen GK, Ebensen T, Gjeraker IH, Svindland S, Bredholt G, Guzman CA, et al. Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP. PLoS One 2011;6:e26973; PMID:22069479; http://dx.doi.org/10.1371/journal. pone.0026973
51. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003;425:516-21; PMID: 14520412; http://dx.doi.org/10.1038/nature01991
52. Roberts ZJ, Goutagny N, Perera PY, Kato H, Kumar H, Kawai T, et al. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J Exp Med 2007;204:1559-69; PMID: 17562815; http://dx.doi.org/ 10.1084/jem.20061845
53. Tang CK, Aoshi T, Jounai N, Ito J, Ohata K, Kobiyama K, et al. The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant. PLoS One 2013;8:e60038; PMID:23555875; http://dx.doi.org/10.1371/journal, pone. 0060 038
54. Caviar T, Deimling T, Ablasser A, Hopfner KP, Hornung V. Species-specific detection of the antiviral small-molecule compound CM A by STING. EMBO J 2013;32:1440-50; PMID:23604073; http://dx.doi.org/10.1038/emboj.2013.86
55. Conlon J, Burdette DL, Sharma S, Bhat N, Thompson M, Jiang Z, et al. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5, 6-dimethylxanthenone-4-acetic acid. J Immunol 2013;190:5216-25; PMID:23585680; http://dx. doi.org/10.4049/j immuno1.1300097